
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS-CoV-2 spike engagement of ACE2 primes S2′ site cleavage and fusion initiation
Yu Shi, Xu Zheng, Bingjie Zhou, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 119, Iss. 1
Open Access | Times Cited: 107
Yu Shi, Xu Zheng, Bingjie Zhou, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 119, Iss. 1
Open Access | Times Cited: 107
Showing 1-25 of 107 citing articles:
SARS-CoV-2 variant biology: immune escape, transmission and fitness
Alessandro M. Carabelli, Thomas P. Peacock, Lucy Thorne, et al.
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 989
Alessandro M. Carabelli, Thomas P. Peacock, Lucy Thorne, et al.
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 989
ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies
Jun Siong Low, Josipa Jerak, M. Alejandra Tortorici, et al.
Science (2022) Vol. 377, Iss. 6607, pp. 735-742
Open Access | Times Cited: 146
Jun Siong Low, Josipa Jerak, M. Alejandra Tortorici, et al.
Science (2022) Vol. 377, Iss. 6607, pp. 735-742
Open Access | Times Cited: 146
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity
Rachid Essalmani, Jaspreet Jain, Delia Susan‐Resiga, et al.
Journal of Virology (2022) Vol. 96, Iss. 8
Open Access | Times Cited: 134
Rachid Essalmani, Jaspreet Jain, Delia Susan‐Resiga, et al.
Journal of Virology (2022) Vol. 96, Iss. 8
Open Access | Times Cited: 134
Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines
Liyan Guo, Sheng Lin, Zimin Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 48
Liyan Guo, Sheng Lin, Zimin Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 48
Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic
Wilhelm Furnon, Vanessa M. Cowton, Giuditta De Lorenzo, et al.
Nature Microbiology (2025)
Open Access | Times Cited: 2
Wilhelm Furnon, Vanessa M. Cowton, Giuditta De Lorenzo, et al.
Nature Microbiology (2025)
Open Access | Times Cited: 2
Spike protein mediated membrane fusion during SARS‐CoV‐2 infection
Xinyu Li, Huijun Yuan, Xiaozhen Li, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 45
Xinyu Li, Huijun Yuan, Xiaozhen Li, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 45
The role of vaccines in the COVID-19 pandemic: what have we learned?
Florian Krammer
Seminars in Immunopathology (2023) Vol. 45, Iss. 4-6, pp. 451-468
Open Access | Times Cited: 41
Florian Krammer
Seminars in Immunopathology (2023) Vol. 45, Iss. 4-6, pp. 451-468
Open Access | Times Cited: 41
PLSCR1 is a cell-autonomous defence factor against SARS-CoV-2 infection
Dijin Xu, Weiqian Jiang, Lizhen Wu, et al.
Nature (2023) Vol. 619, Iss. 7971, pp. 819-827
Open Access | Times Cited: 37
Dijin Xu, Weiqian Jiang, Lizhen Wu, et al.
Nature (2023) Vol. 619, Iss. 7971, pp. 819-827
Open Access | Times Cited: 37
Single-molecule imaging reveals allosteric stimulation of SARS-CoV-2 spike receptor binding domain by host sialic acid
Marco A. Díaz-Salinas, Aastha Jain, Natasha D. Durham, et al.
Science Advances (2024) Vol. 10, Iss. 29
Open Access | Times Cited: 9
Marco A. Díaz-Salinas, Aastha Jain, Natasha D. Durham, et al.
Science Advances (2024) Vol. 10, Iss. 29
Open Access | Times Cited: 9
Discovering natural products as potential inhibitors of SARS-CoV-2 spike proteins
Muhammad Alqaaf, Ahmad Kamal Nasution, Mohammad Bozlul Karim, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Muhammad Alqaaf, Ahmad Kamal Nasution, Mohammad Bozlul Karim, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
SARS-CoV-2 accessory proteins reveal distinct serological signatures in children
Asmaa Hachim, Haogao Gu, Otared Kavian, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 29
Asmaa Hachim, Haogao Gu, Otared Kavian, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 29
Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences
Alessandra Aiello, Saeid Najafi Fard, Delia Goletti
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Alessandra Aiello, Saeid Najafi Fard, Delia Goletti
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Mechanism and evolution of human ACE2 binding by SARS-CoV-2 spike
Antoni G. Wrobel
Current Opinion in Structural Biology (2023) Vol. 81, pp. 102619-102619
Open Access | Times Cited: 21
Antoni G. Wrobel
Current Opinion in Structural Biology (2023) Vol. 81, pp. 102619-102619
Open Access | Times Cited: 21
SARS-CoV-2 Spike Protein Is Capable of Inducing Cell–Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies
Nina Reuter, Xiaohan Chen, Barbara Kropff, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1500-1500
Open Access | Times Cited: 20
Nina Reuter, Xiaohan Chen, Barbara Kropff, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1500-1500
Open Access | Times Cited: 20
Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity
Harry Ridgway, Charalampos Ntallis, Christos T. Chasapis, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 309-309
Open Access | Times Cited: 17
Harry Ridgway, Charalampos Ntallis, Christos T. Chasapis, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 309-309
Open Access | Times Cited: 17
Kaempferol inhibits SARS-CoV-2 invasion by impairing heptad repeats-mediated viral fusion
Junwei Gao, Can Cao, Mingfei Shi, et al.
Phytomedicine (2023) Vol. 118, pp. 154942-154942
Open Access | Times Cited: 17
Junwei Gao, Can Cao, Mingfei Shi, et al.
Phytomedicine (2023) Vol. 118, pp. 154942-154942
Open Access | Times Cited: 17
Functional and antigenic characterization of SARS-CoV-2 spike fusion peptide by deep mutational scanning
Ruipeng Lei, Enya Qing, Abby Odle, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Ruipeng Lei, Enya Qing, Abby Odle, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron
Mehdi Benlarbi, Geneviève Laroche, Corby Fink, et al.
iScience (2022) Vol. 25, Iss. 11, pp. 105316-105316
Open Access | Times Cited: 27
Mehdi Benlarbi, Geneviève Laroche, Corby Fink, et al.
iScience (2022) Vol. 25, Iss. 11, pp. 105316-105316
Open Access | Times Cited: 27
S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review
Reza Nejat, Maziar Fayaz Torshizi, David J. Najafi
Vaccines (2023) Vol. 11, Iss. 2, pp. 204-204
Open Access | Times Cited: 16
Reza Nejat, Maziar Fayaz Torshizi, David J. Najafi
Vaccines (2023) Vol. 11, Iss. 2, pp. 204-204
Open Access | Times Cited: 16
Host heparan sulfate promotes ACE2 super-cluster assembly and enhances SARS-CoV-2-associated syncytium formation
Qi Zhang, Weichun Tang, Eduardo Stancanelli, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Qi Zhang, Weichun Tang, Eduardo Stancanelli, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Current Status and Perspectives of Therapeutic Antibodies Targeting the Spike Protein S2 Subunit against SARS-CoV-2
Yuichiro Yamamoto, Tetsuya Inoue
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 5, pp. 917-923
Open Access | Times Cited: 5
Yuichiro Yamamoto, Tetsuya Inoue
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 5, pp. 917-923
Open Access | Times Cited: 5
Antibody-mediated immunity to SARS-CoV-2 spike
John M. Errico, Lucas J. Adams, Daved H. Fremont
Advances in immunology (2022), pp. 1-69
Open Access | Times Cited: 21
John M. Errico, Lucas J. Adams, Daved H. Fremont
Advances in immunology (2022), pp. 1-69
Open Access | Times Cited: 21
In silico analysis of mutations near S1/S2 cleavage site in SARS‐CoV‐2 spike protein reveals increased propensity of glycosylation in Omicron strain
Christopher A. Beaudoin, Arun Prasad Pandurangan, So Yeon Kim, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 9, pp. 4181-4192
Open Access | Times Cited: 20
Christopher A. Beaudoin, Arun Prasad Pandurangan, So Yeon Kim, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 9, pp. 4181-4192
Open Access | Times Cited: 20
Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its conformation, fusogenicity, and neutralization sensitivity
Sahil Kumar, Rathina Delipan, Debajyoti Chakraborty, et al.
Journal of Virology (2023) Vol. 97, Iss. 11
Open Access | Times Cited: 11
Sahil Kumar, Rathina Delipan, Debajyoti Chakraborty, et al.
Journal of Virology (2023) Vol. 97, Iss. 11
Open Access | Times Cited: 11
SARS-CoV-2 variant biology and immune evasion
Asiya Kamber Zaidi, Rohan Bir Singh
Progress in molecular biology and translational science (2024), pp. 45-66
Closed Access | Times Cited: 4
Asiya Kamber Zaidi, Rohan Bir Singh
Progress in molecular biology and translational science (2024), pp. 45-66
Closed Access | Times Cited: 4